To further explore the role of these AFP trajectory groups on HCC patient prognosis, we evaluated the OS, PFS and IRFS for each trajectory group by survival and cumulative hazard curves (Figure 3, Figure S4). The gene discussed is AFP; the disease is hepatocellular carcinoma.